Concepedia

James Tseng

JT

Statistics

Publications

3

Citations

81

H-Index

3

Active since

1980

Affiliations

Eli Lilly (United States)(Current)

Eli Lilly (United Kingdom)

Eli Lilly (Singapore)

James Tseng is an author at Eli Lilly (United States) specializing in tau-targeted therapy, alzheimer disease progression, and enzyme inhibition.

Publications per year

1980–2020

3

Publications

3

Purification and characterization of exocellular proteases produced by a clinical isolate and a laboratory strain of <i>Pseudomonas aeruginosa</i>

Susan E. Jensen, Lucille M. Phillippe, James Tseng et al. · Canadian Journal of Microbiology · 1980 · 49 citations

, , +12

Brain target occupancy of LY3372689, an inhibitor of the O‐GlcNAcase (OGA) enzyme: Translation from rat to human

Sergey Shcherbinin, William Kielbasa, Susan L. DuBois et al. · Alzheimer s & Dementia · 2020 · 21 citations · Full text

, , +17

A single ascending dose study in healthy volunteers to assess the safety and PK of LY3372689, an inhibitor of O‐GlcNAcase (OGA) enzyme

William Kielbasa, Krista M Phipps, James Tseng et al. · Alzheimer s & Dementia · 2020 · 11 citations

, , +17

1–3 of 3